India to Congo: Levamisole Export Trade Route
India has recorded 48 verified shipments of Levamisole exported to Congo, representing a combined trade value of $462.1K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $9.6K USD. The leading Indian exporter is DOSCH PHARMACEUTICALS PRIVATE LIMITED, which accounts for 26% of total export value with 19 shipments worth $122.1K USD. On the buying side, NA is the largest importer in Congo with $146.1K USD in purchases. The top 3 suppliers — DOSCH PHARMACEUTICALS PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED — together control 62% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Congo Levamisole corridor is one of India's established pharmaceutical export routes, with 48 shipments documented worth a combined $462.1K USD. The route is dominated by DOSCH PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's levamisole manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $9.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 13.8%, placing it at rank #4 among India's top levamisole export destinations globally.
On the import side, key buyers of Indian levamisole in Congo include NA, STE PRINCE PHARMA SARL, STE PRINCE PHARMA SARL and 6 others. NA is the single largest importer with 11 shipments valued at $146.1K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#4
- Annual growth+13.8%
- Demand growth+12.1%
- Regulatory ease67/100
Top 10 Indian Levamisole Exporters to Congo
Showing top 10 of 8 Indian suppliers exporting Levamisole to Congo, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DOSCH PHARMACEUTICALS PRIVATE LIMITED Avg $6.4K per shipment | 19 | $122.1K | 26.4% |
| 2 | PRASHI PHARMA PRIVATE LIMITED Avg $9.9K per shipment | 10 | $99.2K | 21.5% |
| 3 | PRASHI PHARMA PRIVATE LIMITED Avg $12.8K per shipment | 5 | $64.1K | 13.9% |
| 4 | DOSCH PHARMACEUTICALS PRIVATE LIMITED Avg $12.6K per shipment | 5 | $62.8K | 13.6% |
| 5 | AMBADNYA LIFE SCIENCE LLP Avg $22.8K per shipment | 2 | $45.6K | 9.9% |
| 6 | AXELIA Avg $14.5K per shipment | 2 | $29.0K | 6.3% |
| 7 | VIDACARE MEDICA PRIVATE LIMITED Avg $8.7K per shipment | 3 | $26.2K | 5.7% |
| 8 | AMBADNYA LIFE SCIENCE LLP Avg $6.6K per shipment | 2 | $13.1K | 2.8% |
This table shows the top 10 of 8 Indian companies exporting levamisole to Congo, ranked by total trade value. The listed exporters are: DOSCH PHARMACEUTICALS PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED , DOSCH PHARMACEUTICALS PRIVATE LIMITED , AMBADNYA LIFE SCIENCE LLP, AXELIA , VIDACARE MEDICA PRIVATE LIMITED, AMBADNYA LIFE SCIENCE LLP . DOSCH PHARMACEUTICALS PRIVATE LIMITED is the dominant supplier with 19 shipments worth $122.1K USD, giving it a 26% market share. The top 3 suppliers together account for 62% of the total trade value on this route.
Top 10 Levamisole Importers in Congo
Showing top 10 of 9 known buyers in Congo receiving Levamisole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian levamisole in Congo include NA, STE PRINCE PHARMA SARL, STE PRINCE PHARMA SARL , TO THE ORDER, PRINCEPHARMA SARL / ETS MINDA /, among 9 total buyers. The largest importer is NA, accounting for $146.1K USD across 11 shipments — representing 32% of all levamisole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 11 | $146.1K | 31.6% |
| 2 | STE PRINCE PHARMA SARL | 13 | $125.4K | 27.1% |
| 3 | STE PRINCE PHARMA SARL | 5 | $64.1K | 13.9% |
| 4 | TO THE ORDER | 11 | $36.9K | 8.0% |
| 5 | PRINCEPHARMA SARL / ETS MINDA / | 1 | $30.4K | 6.6% |
| 6 | MEDICO PLUS | 2 | $29.0K | 6.3% |
| 7 | PRINCE PHARMA SARL | 1 | $15.2K | 3.3% |
| 8 | UNIQUE PHARMA | 2 | $13.1K | 2.8% |
| 9 | TO THE ORDER | 2 | $1.8K | 0.4% |
Top 10 Levamisole Formulations Imported by Congo
Showing top 10 of 18 product formulations shipped on the India to Congo Levamisole route, ranked by trade value
Congo imports a wide range of levamisole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LEVAMISOLE HYDROCHLORIDE TABLETS 150 MG — accounts for $60.8K USD across 4 shipments. There are 18 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEVAMISOLE HYDROCHLORIDE TABLETS 150 MG | 4 | $60.8K | 13.1% |
| 2 | Levamisole HCL Tablets 150 Mg | 4 | $49.5K | 10.7% |
| 3 | HARMLESS MEDICINES, LEVAMISOLE HCL TABLE | 2 | $45.6K | 9.9% |
| 4 | LEVAMISOLE HYDROCHLORIDE TABLETS 50 MG E | 4 | $43.2K | 9.3% |
| 5 | LEVAMISOLE HCL TABLETS 50 MG | 4 | $41.3K | 8.9% |
| 6 | MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLATIC USES PHARMACEUTICAL ITEM - LEVAMISOLENOS | 11 | $36.9K | 8.0% |
| 7 | LEVAMISOLE HYDROCHLORIDE TABLETS 50 MG E | 3 | $36.6K | 7.9% |
| 8 | Levamisole HCL Tablet USP 50 mg ( 29600 | 2 | $29.0K | 6.3% |
| 9 | LEVAMISOLE HCL TABLETS 50 MG EACH UNCOATED TABLET CONTAINS LEVAMISOLE HCL EQ TO LEVAMISOLE BP 50 MG | 2 | $23.4K | 5.1% |
| 10 | LEVAMISOLE HYDROCHLORIDE TABLETS 150 MG | 3 | $22.8K | 4.9% |
Showing top 10 of 18 Levamisole formulations imported by Congo on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 26 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's levamisole exports to Congo are driven primarily by a handful of large-scale manufacturers. DOSCH PHARMACEUTICALS PRIVATE LIMITED with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Congo benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DOSCH PHARMACEUTICALS PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED — together account for 62% of total trade value on this route. The average shipment value of $9.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as levamisole hcl tablets 150 mg and harmless medicines, levamisole hcl table, suggesting that buyers in Congo tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 11 shipments worth $146.1K USD — representing 32% of all levamisole imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $462.1K
- Avg. Shipment
- $9.6K
- Suppliers
- 8
- Buyers
- 9
- Transit (Sea)
- ~15 days
- Annual Growth
- +13.8%
Related Analysis
Other Levamisole Routes
Unlock the Full India to Congo Levamisole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 48 shipments on this route.
Frequently Asked Questions — India to Congo Levamisole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Levamisole to Congo?
The leading Indian exporters of Levamisole to Congo are DOSCH PHARMACEUTICALS PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED, PRASHI PHARMA PRIVATE LIMITED . DOSCH PHARMACEUTICALS PRIVATE LIMITED holds the largest market share at approximately 26% of total trade value on this route.
Q What is the total value of Levamisole exports from India to Congo?
India exports Levamisole to Congo worth approximately $462.1K USD across 48 recorded shipments. The average value per shipment is $9.6K USD.
Q Which ports does India use to ship Levamisole to Congo?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 26 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Congo for Levamisole?
The average transit time for Levamisole shipments from India to Congo is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Congo Levamisole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.8% with demand growth tracking at 12.1%. The route is ranked #4 among India's top Levamisole export destinations globally.
Q How many suppliers are active on the India to Congo Levamisole route?
There are currently 8 active Indian suppliers exporting Levamisole to Congo. The market is moderately concentrated with DOSCH PHARMACEUTICALS PRIVATE LIMITED accounting for 26% of total shipment value.
Q Who are the main importers of Levamisole from India in Congo?
The leading importers of Indian Levamisole in Congo include NA, STE PRINCE PHARMA SARL, STE PRINCE PHARMA SARL , TO THE ORDER, PRINCEPHARMA SARL / ETS MINDA /. NA is the largest buyer with 11 shipments worth $146.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Congo export trade corridor identified from Indian Customs (DGFT) records for Levamisole.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 9 importers in Congo matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 48 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
48 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists